|
Sue Siegel has spent more than two decades commercializing key enabling technologies in biomedical research and healthcare. Prior to joining MDV, Ms. Siegel was President and Director of Affymetrix, Inc., a company which helped propel the expansion of the genomics field and the opportunity for personalized medicine. Formerly, Ms. Siegel was at Amersham International (now GE) where she held senior executive roles, including President of Hoefer-Pharmacia Biotech. She was also involved in commercializing key biomedical technologies at E. I. DuPont & Co., Eastman Kodak Co., and Bio-Rad Laboratories. Additionally, Ms. Siegel serves on the board of The Tech Museum of Innovation, is a member of the Presidents' Circle of the National Academies, and serves as an advisor to the Institute of Medicine. Ms. Siegel received her B.S. in Biology from the University of Puerto Rico and holds a M.S. in Biochemistry and Molecular Biology from Boston University Medical School. | 